This article is more than 5 years old. Information may no longer be current.
Top cardiology news of June: Premature death prevention, e-cigarettes and more
Cardiology Today compiled a list of the most-read articles in June on Healio.com/Cardiology. This month, our readers were interested in prevention of premature death, cardiologists’ role in diabetes care, the CV risk of e-cigarettes and more.
More focus on BP control, diet may prevent 94.3 million premature deaths
BP control, sodium intake reduction and trans fatty acid elimination may prevent nearly 100 million global deaths within a 25-year period, according to a study published in Circulation.
Cardiologists' role in diabetes care changing
As rates of type 2 diabetes continue to rise worldwide, the cardiology community continues to care for increasing number of patients with CVD and diabetes. Moreover, the shortage of endocrinologists in the United States currently available to care for patients with diabetes further complicates this issue.
E-cigarettes and CV risk: Current state of the evidence for cardiologists
Given the popularity of e-cigarette use and concerns about potential CV toxicity, there has been considerable interest in understanding CV risks that may attend the use of these products, in absolute terms, and relative to conventional cigarette smoking.
Increasing vitamin K intake may stabilize anticoagulation in patients using warfarin
Among patients with thromboembolic disease treated with warfarin, increased consumption of foods containing vitamin K may improve anticoagulant stability, according to findings presented at the American Society for Nutrition Annual Nutrition Science Meeting.
Next Gen Innovator wins award for paper on His bundle pacing
Cardiology Today Next Gen Innovator Parikshit S. Sharma, MD, MPH, FACC, FHRS, and colleagues won the Joan and Douglas P. Zipes Publication of the Year Award presented in May at the Heart Rhythm Society Annual Scientific Sessions.
FDA: Symptom improvement alone may be basis of approval for HF drugs
The FDA announced it has issued draft guidance on drug development for HF treatments, which indicates that an effect on physical function or symptoms without favorable effects on hospitalization or survival can be a basis for approval.
RADAR: Persistent AF ablation guided by novel mapping system successful
SAN FRANCISCO — A novel mapping system to identify drivers of atrial fibrillation beyond the pulmonary vein was associated with successful AF ablation at 9 months, according to the RADAR study presented at the Heart Rhythm Society Annual Scientific Sessions.
HDL apolipoproteomic score may predict risk for CV death in CAD
An HDL apolipoproteomic score was linked to the presence of CAD in patients without prevalent MI who were referred for coronary angiography, according to a study published in the Journal of the American College of Cardiology.
In metabolic syndrome, telemonitored exercise may improve health
The use of telemonitoring in exercise-based intervention initiatives for adults with metabolic syndrome may lead to reduced severity of the condition, according to findings published in The Lancet Public Health.
Exercise-based cardiac rehab confers improvements in HF
Exercise-based cardiac rehabilitation in patients with HF resulted in improvements in exercise capacity and health-related quality of life compared with patients who did not exercise, according to a study published in the Journal of the American College of Cardiology.